ENGN
#3850
enGene Therapeutics Inc. - Common Stock
1.8 3 USD
-0.04%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-4.19%
Variación mensual
+2.23%
Variación en los últimos 6 meses
-81.16%
Cambio anual
-78.21%
Cierres anteriores
1.9 1
Open
1.8 3
Mínimo
1.8 3
Máximo
1.8 3
Volumen
10
Financials
- Market Capitalization 122.59 M
- Employee 82
- Founded N/A
- CEO N/A
- Website www.engene.com
- Headquarter Canada (Federal Level)
- FIGI BBG01J1GCYW7
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
3.12
Relación precio/flujo de caja
-967.67
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3837 |  CBUS Cibus, Inc. - Class A Common Stock | 1.65 USD | -1.20% | -2.37% | -14.51% | +25.00% | 126.11 M USD | ||
| 3842 |  BMEA Biomea Fusion, Inc. - Common Stock | 1.73 USD | +2.98% | +15.33% | +47.86% | -11.73% | 125.40 M USD | ||
| 3852 |  TLSA Tiziana Life Sciences Ltd - Common Shares | 1.01 USD | -6.48% | -11.40% | +1.00% | -43.26% | 121.71 M USD | ||
| 3854 |  NTHI NeOnc Technologies Holdings, Inc. - Common Stock | 4.69 USD | +1.74% | -0.42% | +36.34% | -46.49% | 121.64 M USD |